Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Telmisartan
Drug ID BADD_D02147
Description Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects.
Indications and Usage Used alone or in combination with other classes of antihypertensives for the treatment of hypertension. Also used in the treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes mellitus, as well as the treatment of congestive heart failure (only in patients who cannot tolerate ACE inhibitors).
Marketing Status approved; investigational
ATC Code C09CA07
DrugBank ID DB00966
KEGG ID D00627
MeSH ID D000077333
PubChem ID 65999
TTD Drug ID D0N6RF
NDC Product Code 72606-506; 10695-139; 65841-805; 68462-199; 68462-200; 72606-507; 55111-095; 62135-536; 62135-537; 62332-089; 65162-293; 71209-049; 52286-0024; 53104-7624; 65404-007; 42291-792; 42571-226; 62135-535; 62332-087; 0597-0041; 72241-017; 65841-804; 65862-868; 68071-2591; 72241-015; 72241-016; 65372-1146; 42291-790; 46708-608; 53002-1794; 71335-1428; 71335-2173; 12666-0010; 50370-0015; 64220-124; 65862-727; 68554-0049; 42571-227; 43547-284; 43547-285; 53746-291; 63629-5682; 0378-2920; 67877-482; 68382-472; 68382-473; 70518-3556; 0597-0039; 65404-006; 66039-895; 71052-679; 45865-836; 53746-292; 65841-806; 65862-867; 68071-5178; 71335-1723; 57451-1206; 46708-610; 67877-483; 68788-8440; 68788-8441; 70518-3300; 0597-0040; 62512-0040; 64552-4026; 65015-845; 42291-791; 43547-283; 53746-293; 62332-088; 0378-2921; 65862-869; 67877-484; 68462-201; 70518-2572; 71209-050; 71209-051; 72606-508; 52562-009; 72761-021; 42571-228; 46708-609; 50090-5490; 63187-951; 0378-2922; 65162-291; 65162-292; 68382-471; 71335-2191; 62331-032; 64220-171
UNII U5SYW473RQ
Synonyms Telmisartan | 4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid | Pritor | BIBR 277 | BIBR-277 | Micardis
Chemical Information
Molecular Formula C33H30N4O2
CAS Registry Number 144701-48-4
SMILES CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ingrowing nail23.02.05.0110.000260%Not Available
Insomnia17.15.03.002; 19.02.01.002--
Intermittent claudication24.04.03.001--Not Available
Interstitial lung disease22.01.02.003; 10.02.01.0330.003905%Not Available
Intestinal obstruction07.13.01.0020.000260%Not Available
Jaundice01.06.04.004; 23.03.03.030; 09.01.01.0040.000260%Not Available
Jaundice cholestatic09.01.01.0050.000521%Not Available
Joint swelling15.01.02.0040.000521%Not Available
Kidney fibrosis20.01.02.0110.000260%Not Available
Labile blood pressure24.06.01.0010.000651%Not Available
Lactic acidosis14.01.01.0020.000390%Not Available
Laryngeal oedema10.01.05.003; 23.04.01.005; 22.04.02.0010.000390%
Libido decreased21.03.02.005; 19.08.03.0010.000963%
Lip oedema10.01.05.004; 23.04.01.006; 07.05.04.0040.000260%Not Available
Lip swelling07.05.04.005; 23.04.01.007; 10.01.05.0050.000390%Not Available
Liver disorder09.01.08.0010.000521%Not Available
Loss of consciousness17.02.04.0040.001952%Not Available
Lung disorder22.02.07.001--Not Available
Lymphoma16.20.01.001; 01.12.01.0010.000260%Not Available
Malabsorption14.02.01.004; 07.17.01.0010.000781%
Malaise08.01.01.0030.003748%
Melaena24.07.02.013; 07.12.02.0040.000260%Not Available
Metabolic acidosis14.01.01.0030.000390%Not Available
Micturition disorder20.02.02.005--Not Available
Migraine24.03.05.003; 17.14.02.001--Not Available
Mitral valve incompetence02.07.01.0020.000260%Not Available
Muscle contractions involuntary17.05.03.001; 15.05.03.008--Not Available
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.001--
Myalgia15.05.02.0010.001223%
The 7th Page    First    Pre   7 8 9 10 11    Next   Last    Total 14 Pages